文献速递脑血管病外科神经重症小儿神经外科与脑积水

动脉瘤性蛛网膜下腔出血后脑积水患者脑室外引流终止管理:斯堪的纳维亚多中心调查

Discontinuation of External Ventricular Drainage in Patients with Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage - a Scandinavian Multi-institutional Survey.
PubMed 文献 · Acta Neurochir (Wien) · 2020-04-22

该调查向斯堪的纳维亚全部14个神经外科科室发放关于动脉瘤性蛛网膜下腔出血后脑积水患者脑室外引流终止管理的问卷,2018年5月至2019年4月共回收175份(应答率64%)。85%的应答者不知晓相关国际指南,各科室内部对是否遵循统一终止策略存在分歧;多数主张在aSAH发病后4-7天、引流量<150 ml/天且颅内压<15 mmHg的稳定患者中启动终止。

要点

  • 85%应答者不知晓aSAH后脑积水患者脑室外引流终止的国际指南。
  • 同一科室内部对应答者是否遵循统一终止策略存在分歧。
  • 普遍认同的启动条件为aSAH发病后4-7天、引流量<150 ml/天且颅内压<15 mmHg且病情稳定。

核心结论

  • 斯堪的纳维亚地区对aSAH后脑积水患者脑室外引流终止相关国际指南的知晓率和依从性有限。
  • 科室层面缺乏内部共识。
  • 终止流程的启动似乎取决于个案,主要受患者临床状况和引流量影响。
  • 格拉斯哥昏迷评分(GCS)被认为是决定启动终止时最重要的临床变量。

研究设计与样本

  • 向斯堪的纳维亚(挪威、瑞典和丹麦)全部14个神经外科科室发放关于aSAH后脑积水患者脑室外引流终止管理的问卷。
  • 要求各级神经外科医生和神经外科受训人员独立完成问卷。
  • 2018年5月至2019年4月共收到175份完成的问卷,应答率64%。

主要发现

  • 85%的应答者报告不知晓关于aSAH后脑积水患者脑室外引流终止的国际指南。
  • 在每个科室内部,应答者对是否遵循统一终止策略存在分歧。
  • 74%的应答者主要根据患者临床状况和引流量决定脑室外引流终止策略。
  • 45%的应答者认为GCS是评估脑室外引流终止时机时最重要的临床变量。
  • 普遍认同在aSAH发病后4-7天、引流量<150 ml/天且颅内压<15 mmHg的稳定患者中启动脑室外引流终止。

关键数值与推荐

  • 启动脑室外引流终止的普遍认同条件为aSAH发病后4-7天、引流量<150 ml/天且颅内压<15 mmHg且患者病情稳定。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hydrocephalus requiring external ventricular drainage is common following aneurysmal subarachnoid hemorrhage (aSAH). Timing and strategy for the discontinuation of the external ventricular drain (EVD) are, however, controversial as guidelines are based on limited scientific evidence. A recent similar survey showed that guidelines and recommendations are not being followed. We conducted a questionnaire survey regarding the management of EVD treatment in patients with aSAH and investigated current treatment practice, consensus, and adherence to guidelines within the neurosurgical departments in Scandinavia. METHODS: A questionnaire concerning the management of EVD discontinuation in patients with hydrocephalus following aSAH was distributed to all 14 neurosurgical departments in Scandinavia (Norway, Sweden, and Denmark). Neurosurgeons and neurosurgical trainees at all levels were asked to complete the questionnaire individually. A total of 175 completed questionnaires were received between May 2018 and April 2019, resulting in a response rate of 64 %. RESULTS: Eighty-five percent of respondents reported no knowledge of international guidelines regarding EVD discontinuation in patients with hydrocephalus following aSAH. Within every department, respondents disagreed on whether a common discontinuation strategy was followed or not. Seventy-four percent decided upon the EVD discontinuation strategy mainly determined by patients' clinical condition and drainage volume. Forty-five percent considered Glasgow Coma Score (GCS) the most important clinical variable when assessing the timing of EVD discontinuation. There was general agreement towards the initiation of EVD discontinuation 4-7 days after ictus of aSAH in a stable patient with a drainage volume of < 150 ml/day and intracranial pressure (ICP) < 15 mmHg. CONCLUSION: Awareness of and adherence to international guidelines regarding EVD discontinuation in patients with hydrocephalus following aSAH were limited in Scandinavia. Internal consensus at department level was absent. Initiation of the discontinuation process appeared to be case dependent and mainly influenced by the patients' clinical condition and drainage volume. GCS was the clinical variable considered most important when deciding on the initiation of EVD discontinuation.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Capion T, Lilja-Cyron A, Bartek J, et al. Discontinuation of External Ventricular Drainage in Patients with Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage - a Scandinavian Multi-institutional Survey. Acta Neurochir (Wien). 2020. PMID: 32322997. doi:10.1007/s00701-020-04317-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。